Author

GIORGIO LELLI

A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours

2005 · J.-L. Pico, G. Rosti, et al. · Annals of Oncology · 289

Correlation of adverse effects of cisplatin administration in patients affected by solid tumours: A retrospective evaluation

2013 · LAURA ASTOLFI, SARA GHISELLI, et al. · Oncology Reports · 241

PDF

Effect of age and single versus multiple dose pharmacokinetics of letrozole (Femara®) in breast cancer patients

2001 · Christian U. Pfister, Antonio Martoni, et al. · Biopharmaceutics & Drug Disposition · 102

Transitional Cell Carcinoma of the Upper Urinary Tract: Evaluation of Prognostic Factors by Histopathology and Flow Cytometric Analysis

1991 · Francesco Corrado, Claudio Ferri, et al. · The Journal of Urology · 83

Association of CYP1B1 with hypersensitivity induced by Taxane therapy in breast cancer patients

2010 · Roberta Rizzo, Federica Spaggiari, et al. · Breast Cancer Research and Treatment · 64

PDF

Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX

2017 · Jean-François Emile, Catherine Julié, et al. · European Journal of Cancer · 49

Capecitabine plus oxaliplatin (xelox) versus protracted 5-fluorouracil venous infusion plus oxaliplatin (pvifox) as first-line treatment in advanced colorectal cancer: A GOAM phase II randomised study (FOCA trial)

2006 · Andrea Angelo Martoni, Carmine Pinto, et al. · European Journal of Cancer · 45

Prospective Phase II Study of Single-Agent Gemcitabine in Untreated Elderly Patients With Stage IIIB/IV Non–Small-Cell Lung Cancer

2001 · Andrea Martoni, Francesca Di Fabio, et al. · American Journal of Clinical Oncology · 43

A randomized phase II study of combination, alternating and sequential regimens of doxorubicin and docetaxel as first-line chemotherapy for women with metastatic breast cancer

2004 · S. Cresta, G. Grasselli, et al. · Annals of Oncology · 38

PDF

Pattern of care and effectiveness of treatment for glioblastoma patients in the real world: Results from a prospective population-based registry. Could survival differ in a high-volume center?

2014 · Alba A. Brandes, Enrico Franceschi, et al. · Neuro-Oncology Practice · 35

PDF

Multicenter randomized clinical trial on high-dose epirubicin plus cis-platinum versus vinorelbine plus cis-platinum in advanced non small cell lung cancer

1998 · A Martoni, M Guaraldi, et al. · Lung Cancer · 35

Depression and serotonin transporter (5-HTTLPR) polymorphism in breast cancer patients

2010 · Luigi Grassi, Elena Rossi, et al. · Journal of Affective Disorders · 24

Treatment of the Cancer Anorexia-Cachexia Syndrome: A Critical Reappraisal

2003 · G. Lelli, M. Montanari, et al. · Journal of Chemotherapy · 21

The anabolic effect of high dose medroxyprogesterone acetate in oncology

1983 · G. Lelli, B. Angelelli, et al. · Pharmacological Research Communications · 20

Standard interleukin-2 (IL-2) and interferon-alpha immunotherapy versus an IL-2 and 4-epirubicin immuno-chemotherapeutic association in metastatic renal cell carcinoma.

1998 · E Naglieri, V Gebbia, et al. · PubMed · 17

5-Fluorouracil and levofolinic acid with or without recombinant interferon-2b in patients with advanced colorectal carcinoma

1999 · Giuseppe Colucci, Evaristo Maiello, et al. · Cancer · 16

Randomized, Controlled, Multicenter Phase III Trial of Standard-Dose Fluorouracil-Epirubicin- Cyclophosphamide (FEC), Compared with Time-Intensive FEC (FEC-G) and Mitoxantrone-Methotrexate-Mitomycin C (MMM-G) in Metastatic Breast Carcinoma

2003 · A.M. Capotorto, L. Pavesi, et al. · Journal of Chemotherapy · 15

Interleukin-2, interferon-alpha and medroxyprogesterone acetate in metastatic renal cell carcinoma.

2002 · Emanuele Naglieri, Massimo Lopez, et al. · PubMed · 15

Differences in the availability of new anti-cancer drugs for Italian patients treated in different regions. Results of analysis conducted by the Italian Society Of Medical Oncology (AIOM).

2010 · Stefania Gori, Massimo Di Maio, et al. · PubMed · 13

The Antiemetic Efficacy and the Cost-Benefit Ratio of Ondansetron Calculated with a New Approach to Health Technology Assessment (Real Cost-Benefit Index)

1992 · S. Tanneberger, G. Lelli, et al. · Journal of Chemotherapy · 13

Gastrointestinal Stromal Tumors and Other Malignancies: a Case Series

2012 · Jacopo Giuliani, Marina Marzola, et al. · Journal of Gastrointestinal Cancer · 12

Multimodal treatment with primary single-agent epirubicin in operable breast cancer: 5-year experience of the Michelangelo Cooperative Group

2002 · G. Bonadonna, M. Zambetti, et al. · Annals of Oncology · 10

The effect of high dose medroxyprogesterone acetate on water and salt metabolism in advanced cancer patients.

1984 · G Lelli, B Angelelli, et al. · PubMed · 10

Hybrid (intravenous and oral) administration of vinorelbine plus cisplatinum followed by oral vinorelbine as first-line therapy of advanced non-small cell lung cancer: A phase II study

2008 · A.A. Martoni, B. Melotti, et al. · Lung Cancer · 7

High-dose cyclophosphamide versus cyclophosphamide, methotrexate, 5-FU, and hydroxyurea (CMFH) in the treatment of stage III non-small cell bronchogenic carcinoma: a randomized trial.

1980 · F Pannuti, G Lelli, et al. · PubMed · 6

Works count: 79

Citation count: 1,300

H-index: 16

I10-index: 23